TrialJournal of pharmacokinetics and pharmacodynamics2024

Employing zero-inflated beta distribution in an exposure-response analysis of TYK2/JAK1 inhibitor brepocitinib in patients with plaque psoriasis.

Nikolaos Tsamandouras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.